Commentary

摘要

The number of studies dedicated to T-cell lympho-mas is increasing, as evidenced by presentations at the 2011 meeting of the American Society of Hematology (ASH). There have been several large, well-designed studies in these rare diseases, which is a very positive development. Most of the larger studies presented at the 2011 ASH meeting provided updates or confirmation of previously presented studies. There were also some early reports describing new, interesting approaches.